Search

Jennifer E. Graser

Examiner (ID: 15, Phone: (571)272-0858 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1802, 1641, 1621
Total Applications
1979
Issued Applications
1306
Pending Applications
236
Abandoned Applications
472

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18589202 [patent_doc_number] => 11738074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Vaccines against malaria transmission [patent_app_type] => utility [patent_app_number] => 17/826617 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 14178 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826617 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/826617
Vaccines against malaria transmission May 26, 2022 Issued
Array ( [id] => 18978851 [patent_doc_number] => 11904005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Compositions and methods of enhancing immune responses to [patent_app_type] => utility [patent_app_number] => 17/824378 [patent_app_country] => US [patent_app_date] => 2022-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9866 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/824378
Compositions and methods of enhancing immune responses to May 24, 2022 Issued
Array ( [id] => 17991286 [patent_doc_number] => 20220357323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => METHOD AND A SOLID SUPPORT FOR DETECTING TICK-BORNE MICROBES IN A BIOLOGICAL SAMPLE [patent_app_type] => utility [patent_app_number] => 17/752277 [patent_app_country] => US [patent_app_date] => 2022-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752277 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/752277
Method and a solid support for detecting tick-borne microbes in a biological sample May 23, 2022 Issued
Array ( [id] => 17828485 [patent_doc_number] => 20220265789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY [patent_app_type] => utility [patent_app_number] => 17/742023 [patent_app_country] => US [patent_app_date] => 2022-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9273 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742023 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/742023
ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY May 10, 2022 Abandoned
Array ( [id] => 20207506 [patent_doc_number] => 20250277226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER [patent_app_type] => utility [patent_app_number] => 18/562157 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562157 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/562157
IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER May 9, 2022 Pending
Array ( [id] => 17792125 [patent_doc_number] => 20220251216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => ANTI HLA-G SPECIFIC ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/728483 [patent_app_country] => US [patent_app_date] => 2022-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728483 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/728483
Anti HLA-G specific antibodies Apr 24, 2022 Issued
Array ( [id] => 19170963 [patent_doc_number] => 20240156937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/278118 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278118 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/278118
BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS Apr 19, 2022 Pending
Array ( [id] => 17774200 [patent_doc_number] => 20220240549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => ACETIC ACID BACTERIA-CONTAINING COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/723123 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723123 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/723123
Acetic acid bacteria-containing composition Apr 17, 2022 Issued
Array ( [id] => 18666279 [patent_doc_number] => 11773157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Compositions and methods for treating and preventing [patent_app_type] => utility [patent_app_number] => 17/659466 [patent_app_country] => US [patent_app_date] => 2022-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 11268 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659466 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/659466
Compositions and methods for treating and preventing Apr 14, 2022 Issued
Array ( [id] => 19353062 [patent_doc_number] => 12053487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions [patent_app_type] => utility [patent_app_number] => 17/719674 [patent_app_country] => US [patent_app_date] => 2022-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7446 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/719674
Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions Apr 12, 2022 Issued
Array ( [id] => 19345472 [patent_doc_number] => 20240254435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => VARIANT BACTERIAL STRAINS AND PROCESSES FOR PROTEIN OR BIOMASS PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/553946 [patent_app_country] => US [patent_app_date] => 2022-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553946 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553946
VARIANT BACTERIAL STRAINS AND PROCESSES FOR PROTEIN OR BIOMASS PRODUCTION Apr 6, 2022 Pending
Array ( [id] => 17988869 [patent_doc_number] => 20220354906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => Probiotic Immunomodulatory Compositions [patent_app_type] => utility [patent_app_number] => 17/714205 [patent_app_country] => US [patent_app_date] => 2022-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714205 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/714205
Probiotic immunomodulatory compositions Apr 5, 2022 Issued
Array ( [id] => 19246869 [patent_doc_number] => 20240197853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/554423 [patent_app_country] => US [patent_app_date] => 2022-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554423 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/554423
MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE Apr 4, 2022 Pending
Array ( [id] => 19170961 [patent_doc_number] => 20240156935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => Vaccine Compositions for Trypanosomatids [patent_app_type] => utility [patent_app_number] => 18/552827 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15865 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552827 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/552827
Vaccine Compositions for Trypanosomatids Mar 30, 2022 Pending
Array ( [id] => 19201495 [patent_doc_number] => 20240173394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => IMMUNOGENIC FUSION PROTEIN [patent_app_type] => utility [patent_app_number] => 18/284513 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284513 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/284513
IMMUNOGENIC FUSION PROTEIN Mar 28, 2022 Pending
Array ( [id] => 18664885 [patent_doc_number] => 11771750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Composition and method for generating immunity to [patent_app_type] => utility [patent_app_number] => 17/705461 [patent_app_country] => US [patent_app_date] => 2022-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 10812 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/705461
Composition and method for generating immunity to Mar 27, 2022 Issued
Array ( [id] => 20678145 [patent_doc_number] => 20260116957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-30 [patent_title] => PHARMACEUTICAL COMPOSITION FOR AMELIORATING ACUTE LUNG INJURY AND ACUTE WORSENING OF PULMONARY FIBROSIS [patent_app_type] => utility [patent_app_number] => 18/282975 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282975 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/282975
PHARMACEUTICAL COMPOSITION FOR AMELIORATING ACUTE LUNG INJURY AND ACUTE WORSENING OF PULMONARY FIBROSIS Mar 17, 2022 Pending
Array ( [id] => 18020617 [patent_doc_number] => 20220372116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE [patent_app_type] => utility [patent_app_number] => 17/698645 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698645 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/698645
Optimized crosslinkers for trapping a target on a substrate Mar 17, 2022 Issued
Array ( [id] => 18517645 [patent_doc_number] => 11707515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Modified [patent_app_type] => utility [patent_app_number] => 17/687313 [patent_app_country] => US [patent_app_date] => 2022-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 12942 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687313 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/687313
Modified Mar 3, 2022 Issued
Array ( [id] => 18604703 [patent_doc_number] => 11746153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Binding molecules specific for FcgRIIA and uses thereof [patent_app_type] => utility [patent_app_number] => 17/684018 [patent_app_country] => US [patent_app_date] => 2022-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 47 [patent_no_of_words] => 24416 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684018 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/684018
Binding molecules specific for FcgRIIA and uses thereof Feb 28, 2022 Issued
Menu